stockrow
Saturday 7 November 2026
Export CHRN’s income statement to Excel — free account
ChronoScale Holdings Corporation
CHRN Technology Information Technology Services
- Revenue
- +148.1%
- EPS
- −256.7%
- Free cash flow
- +1,410.9%
- Total debt
- +337.2%
Quarter to August 2026, against a year earlier
10.82
0.66
+6.50%
Follow CHRN
Alert me
| Older periods | Dec '25 | Mar '26 | May '26 | Aug '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(184.48%) | (327.74%) | 0.00% | (69.19%) | |
Piotroski F-Score |
3 | — | — | 5 | |
| (85.74%) | (103.12%) | 0.00% | (34.99%) | ||
ROIC |
(105.02%) | (281.58%) | 0.00% | (15.32%) | |
Return on Tangible Assets |
(299.16%) | (398.60%) | 0.00% | 145.98% | |
Average Days of Receivables |
102.04 | 63.14 | 0.00 | 54.10 | |
Free Cash Flow per Share |
(3.39) | (2.36) | — | 0.01 | |
Free Cash Flow |
(10.91) | (8.42) | — | 1.93 | |
Capital Expenditures |
(1.16) | — | — | (4.18) | |
| Other line items | |||||
Cash ROIC |
(83.88%) | (68.30%) | 0.00% | 1.08% | |
Accounts Receivable Turnover |
3.59 | 4.77 | 0.00 | 7.50 | |
Accounts Payable Turnover |
18.95 | 13.68 | 0.00 | 5.72 | |
Inventory Turnover |
6.02 | 5.85 | — | 0.00 | |
Average Days of Payables |
18.48 | 27.40 | 0.00 | 115.56 | |
Days of Inventory on Hand |
62.28 | 60.41 | — | 0.00 | |
Tax Rate |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
11.59% | 10.01% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
50.74% | 58.84% | — | 70.19% | |
Share Based Compensation of Revenue |
5.98% | (0.96%) | — | 19.19% | |
Interest Coverage |
(1.03) | (51.48) | — | — | |
Operating CF/Net income |
0.49 | 0.35 | — | (0.11) | |
Depreciation/Fixed assets |
12.47 | 12.72 | 0.00 | 0.47 | |
Capex/Depreciation |
(0.07) | 0.00 | — | (0.27) | |
Revenue per Share |
8.13 | 7.36 | — | 0.35 | |
Operating CF per Share |
(3.03) | (2.36) | — | 0.04 | |
Capex per Share |
(0.36) | 0.00 | — | (0.03) | |
Capex to Sales |
0.04 | 0.00 | — | 0.08 |
Columns are period end dates · fundamentals updated 2 Nov 2026